Healthcare
Live Price
Offline$0.7001
+0.00% today
Window Change
-72.00%
Window
Jun 27, 2025 → May 13, 2026
Coverage: 198 bars · Jun 27, 2025 → May 13, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
North America Frac Sand, Inc. (NAFS) is a Healthcare stock with a market cap of $50.00M and listed on OTC. The stock last traded around $0.70 and down 72.0% across the available one-year price window (Jun 27, 2025 → May 13, 2026). Baseline metrics include revenue growth of +37.1%, EPS growth of +30.0%, a dividend yield of 0.0%. What stands out right now is revenue +37.1%, EPS +30.0%, free cash flow +82.3% with operating margin -231.2% and ROIC 24.5%. Valuation already assumes a fairly strong business story at price/sales 372.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NAFS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NAFS
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NAFS Max Drawdown
-100.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for NAFS and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$716.9K
FY Net Income
-$2.0M
-336.7% YoY
Free Cash Flow
-$1.2M
-829.7% YoY
Revenue Growth
+37.1%
EPS Growth
+30.0%
Gross Margin
79.3%
Net Margin
-386.3%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 188K | 137K | 0 | 0 | 717K |
| Gross Profit | 106K | 73K | 0 | 0 | 500K |
| Operating Income | -446K | -702K | -320K | -364K | -2M |
| EBITDA | -597K | -623K | -320K | 0 | 93K |
| Net Income | -1M | -798K | -408K | 838K | -2M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 6K | 10K | 0 | 0 | 23K |
| Total Assets | 326K | 356K | 0 | 0 | 23K |
| Total Liabilities | 2M | 937K | 865K | 449K | 1M |
| Shareholder Equity | -1M | -581K | -865K | -449K | -1M |
| Total Debt | 478K | 275K | 163K | 129K | 307K |
| Net Debt | 472K | 265K | 163K | 129K | 284K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1M
-829.7% YoY
Capital Expenditures
0
Free Cash Flow
1M
-829.7% YoY
Key ratios
Gross Margin
79.3%
Operating Margin
-231.2%
Net Margin
-386.3%
ROE
31.0%
Debt / Equity
-0.30x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.